We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+18.18%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.12B
AUM Growth
+$507M
Cap. Flow
+$424M
Cap. Flow %
37.86%
Top 10 Hldgs %
69.37%
Holding
669
New
238
Increased
59
Reduced
66
Closed
278

Sector Composition

Rank Sector Weight
1 Financials 8.86%
2 Healthcare 4.92%
3 Technology 4.04%
4 Communication Services 3.4%
5 Industrials 2.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWCH
126
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$406K 0.04%
24,775
+22,503
+990% +$352K
NKTR icon
127
Nektar Therapeutics
NKTR
$2.53B
$399K 0.04%
+1,566
New +$405K
SUM
128
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$395K 0.04%
+20,000
New +$372K
GRSVU
129
DELISTED
Gores Holdings V, Inc. Unit
GRSVU
$382K 0.03%
35,500
+10,500
+42% +$108K
UTHR icon
130
CALL
United Therapeutics
UTHR
$22.7B
$378K 0.03%
+10,500
New +$1.38M
MCD icon
131
McDonald's
MCD
$194B
$372K 0.03%
1,733
-46,953
-96% -$10.2M
NUVB icon
132
Nuvation Bio
NUVB
$2.32B
$351K 0.03%
30,000
-11,811
-28% -$123K
ME
133
DELISTED
23andMe Holding Co
ME
$343K 0.03%
+1,500
New +$336K
UFS
134
CALL
DELISTED
DOMTAR CORPORATION (New)
UFS
$337K 0.03%
+159,200
New +$4.53M
C icon
135
CALL
Citigroup
C
$227B
$333K 0.03%
+50,000
New +$2.54M
CCC
136
CCC Intelligent Solutions
CCC
$4.11B
$332K 0.03%
+25,000
New +$304K
FIT
137
PUT
DELISTED
Fitbit, Inc. Class A common stock
FIT
$332K 0.03%
1,214,100
+666,400
+122% +$4.7M
DBRG icon
138
DigitalBridge
DBRG
$2.95B
$329K 0.03%
+17,087
New +$273K
TRIL
139
DELISTED
Trillium Therapeutics Inc.
TRIL
$325K 0.03%
+22,070
New +$318K
NRG icon
140
NRG Energy
NRG
$25B
$324K 0.03%
+8,632
New +$284K
RP
141
DELISTED
RealPage, Inc.
RP
$320K 0.03%
+3,673
New +$241K
DGNR.U
142
DELISTED
Dragoneer Growth Opportunities Corp. Units, each consisting of one Class A ordinary share, and one-f
DGNR.U
$318K 0.03%
22,720
-77,380
-77% -$989K
SVACU
143
DELISTED
Starboard Value Acquisition Corp. Unit
SVACU
$312K 0.03%
+30,321
New +$309K
DSKEW
144
DELISTED
Daseke, Inc. Warrant
DSKEW
$300K 0.03%
1,668,300
-493,152
-23% -$119K
ACB
145
CALL
Aurora Cannabis
ACB
$179M
$298K 0.03%
+29,940
New +$2.18M
OXY icon
146
Occidental Petroleum
OXY
$58.6B
$298K 0.03%
+17,230
New +$236K
ALXN
147
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
$297K 0.03%
32,000
+5,000
+19% +$643K
CZR icon
148
PUT
Caesars Entertainment
CZR
$6.13B
$294K 0.03%
+222,500
New +$14M
ETWO
149
DELISTED
E2open Parent Holdings
ETWO
$293K 0.03%
+27,000
New +$279K
ARGX icon
150
CALL
argenx
ARGX
$54.2B
$291K 0.03%
+5,000
New +$1.37M

Similar funds

Cowen and Company's Q4 2020 Portfolio in Review

As of Q4 2020, Cowen and Company held 669 positions worth $1.12B, up 83% from $613M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Cowen and Company deployed $424M of net new capital in Q4 2020, opening 238 new positions and adding to 59 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 825,000 shares worth $114M.

By sector, the portfolio is most concentrated in Financials at 8.9% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was McDonald's, an estimated $10.2M trimmed.

  • Cowen and Company's largest Q4 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 825,000 shares worth $114M.
  • Cowen and Company added most to Invesco QQQ Trust in Q4 2020, an estimated $68.6M increase.
  • Cowen and Company's biggest Q4 2020 reduction was McDonald's, cutting an estimated $10.2M.
  • Cowen and Company fully exited Nikola Corporation Common Stock in Q4 2020, selling an estimated $40M.
  • Cowen and Company's ten largest holdings make up 69% of its $1.12B portfolio in Q4 2020.
  • Cowen and Company opened 238 new positions and closed 278 in Q4 2020.
  • Cowen and Company's portfolio value rose 83% quarter-over-quarter to $1.12B.

Based on Cowen and Company's 13F filing for Q4 2020, filed 8 Feb 2021.